Liranab
Indication
Liranaftate is a squalene epoxidase inhibitor and cell wall synthesis inhibitor with a chemical structure similar to tolnaftate. It is suitable for the topical treatment of fungal skin infections such as tinea corporis, tinea cruris, tinea cruris, and tinea pedis.
Manufacturer
Shandong Chenlong Pharmaceutical Co., Ltd.
-
Founded in:
2012-10-26 -
Address:
Zhanghuang Industrial Park, Yutai County, Jining City, Shandong Province -
Tax NO.:
91370827056218877J -
Registered Funds:
53.841299 yuan -
Website:
-
Email: